While DNA hypermethylation in AML prevents binding of CTCF (and its partners) leading to structural properties characterized by repression of the SPI1 gene, according to our ChIP data CTCF become recruited upon AZA in the −14.4 Enhancer while other regions were negative (Figure 4). The gene discussed is SPI1; the disease is acute myeloid leukemia.